Volume 20 Issue 11
Nov.  2022
Turn off MathJax
Article Contents
CHU An-zhen, ZHANG Lan. The predictive value of systemic immune-inflammation index for intravenous immunoglobulin resistance in children with Kawasaki disease[J]. Chinese Journal of General Practice, 2022, 20(11): 1884-1888. doi: 10.16766/j.cnki.issn.1674-4152.002727
Citation: CHU An-zhen, ZHANG Lan. The predictive value of systemic immune-inflammation index for intravenous immunoglobulin resistance in children with Kawasaki disease[J]. Chinese Journal of General Practice, 2022, 20(11): 1884-1888. doi: 10.16766/j.cnki.issn.1674-4152.002727

The predictive value of systemic immune-inflammation index for intravenous immunoglobulin resistance in children with Kawasaki disease

doi: 10.16766/j.cnki.issn.1674-4152.002727
Funds:

 2021jyxm1760

  • Received Date: 2022-05-06
    Available Online: 2022-12-30
  •   Objective  To evaluate the predictive value of systemic immune-inflammation index (SII) for intravenous immunoglobulin (IVIG) resistance in children with Kawasaki disease (KD).  Methods  A total of 445 hospitalized children diagnosed with KD and treated with IVIG in the First Affiliated Hospital of University of Science and Technology of China from January 2018 to March 2022 were retrospectively analyzed. According to the presence of IVIG resistance, they were divided into IVIG resistance group and IVIG sensitive group. Stratified analysis was performed according to platelet value. The differences of inflammatory indexes between each group were compared and binary logistic regression was used to analyze the correlation between each inflammatory index and IVIG-resistance in children with KD. Receiver operating characteristic (ROC) curve was used to evaluate the predictive value of each inflammatory index for IVIG-resistance in children with KD.  Results  For all children with KD, inflammatory indexes including N, NLR, PLR, SII, and CRP of the IVIG-resistant group were higher than those of the IVIG-sensitive group (all P < 0.05), and L was lower (P < 0.05). For thrombocytopenia KD children, there was no statistical difference in the values of each inflammatory indexes. For non-thrombocytopenia KD children, the levels of N, NLR and SII of the IVIG-resistant group were higher than those of the IVIG-sensitive group (all P < 0.05). Logistic regression analysis showed that both NLR and SII were independent risk factors for predicting IVIG resistance. ROC curve analysis showed that the sensitivity of NLR for predicting IVIG-resistance in allover the KD children was 55%, and the specificity was 67%. The sensitivity of SII for predicting IVIG-resistance in non-thrombocytopenic KD children was 56%, and the specificity was 64%.  Conclusion  NLR has a strong predictive ability for IVIG-resistance in allover children with KD, and SII has a strong predictive ability for IVIG-resistance in non-thrombocytopenic KD children.

     

  • loading
  • [1]
    中华医学会儿科学分会心血管学组, 中华医学会儿科学分会风湿学组, 中华医学会儿科学分会免疫学组, 等. 川崎病诊断和急性期治疗专家共识[J]. 中华儿科杂志, 2022, 60(1): 6-13.

    The Subspecialty Group of Cardiolgy, The Society of Pediatrics, Chinese Medical Association; The Subspecialty Group of Rheumatology, The Society of Pediatrics, Chinese Medcial Association; The Subspecialty Group of Immunology, The Society of Pediatrics, Chinese Medical Association; et al. The expert consensus on diagnosis and acute-phase treatment of Kawasaki disease[J]. Chinese Journal of Pediatrics, 2022, 60(1): 6-13.
    [2]
    SOSA T, BROWER L, DIVANOVIC A. Diagnosis and management of Kawasaki disease[J]. JAMA Pediatr, 2019, 173(3): 278-279. doi: 10.1001/jamapediatrics.2018.3307
    [3]
    ARANE K, MENDELSOHN K, MIMOUNI M, et al. Japanese scoring systems to predict resistance to intravenous immunoglobulin in Kawasaki disease were unreliable for Caucasian Israeli children[J]. Acta Pediatr, 2018, 107(12): 2179-2184. doi: 10.1111/apa.14418
    [4]
    陈玉萍, 张兰. 不同炎性指标检测在川崎病患儿诊断中的价值[J]. 中华全科医学, 2020, 18(3): 362-364. doi: 10.16766/j.cnki.issn.1674-4152.001247

    CHEN Y P, ZHANG L. The value of different inflammatory indicators in children with Kawasaki disease[J]. Chinese Journal of General Practice, 2020, 18(3): 362-364. doi: 10.16766/j.cnki.issn.1674-4152.001247
    [5]
    YI L P, ZHANG J, ZHONG J R, et al. Elevated levels of platelet activating factor and its acetylhydrolase indicate high risk of Kawasaki disease[J]. J Interferon Cytokine Res, 2020, 40(3): 159-167. doi: 10.1089/jir.2019.0141
    [6]
    KANAI T, TAKESHITA S, KAWAMURA Y, et al. The combination of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as a novel predictor of intravenous immunoglobulin resistance in patients with Kawasaki disease: A multicenter study[J]. Heart Vessels, 2020, 35(10): 1463-1472. doi: 10.1007/s00380-020-01622-z
    [7]
    JOMRICH G, PAIREDER M, KRISTO I, et al. High systemic immune-inflammation index is an adverse prognostic factor for patients with gastroesophageal adenocarcinoma[J]. Ann Surg, 2021, 273(3): 532-541. doi: 10.1097/SLA.0000000000003370
    [8]
    CARPIO-ORANTES L D, GAR ĆIA-MÉNDEZ S, HERNÁNDEZ-HERNÁNDEZ S N. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index in patients with COVID-19-associated pneumonia[J]. Gac Med Mex, 2020, 156(6): 527-531.
    [9]
    陈芃螈, 杨超, 李刚, 等. 系统性免疫-炎症指数对川崎病患儿冠脉扩张的预测价值[J]. 中国免疫学杂志, 2020, 36(16): 2003-2006. doi: 10.3969/j.issn.1000-484X.2020.16.017

    CHEN P Y, YANG C, LI G, et al. Predicting Value of systemic immune-inflammation index for coronary artery dilatation in patients with Kawasaki disease[J]. Chinese Journal of Immunology, 2020, 36(16): 2003-2006. doi: 10.3969/j.issn.1000-484X.2020.16.017
    [10]
    MCCRINDLE B W, ROWLEY A H, NEWBURGER J W, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American heart association[J]. Circulation, 2017, 135(17): e927-e999.
    [11]
    YANG R N, CHANG Q, MENG X C, et al. Prognostic value of systemic immune-inflammation index in cancer: A meta-analysis[J]. J Cancer, 2018, 9(18): 3295-3302. doi: 10.7150/jca.25691
    [12]
    ISHII M, EBATO T, KATO H, et al. History and future of treatment for acute stage Kawasaki disease[J]. Korean Circ J, 2020, 50(2): 112-119. doi: 10.4070/kcj.2019.0290
    [13]
    WU G, YUE P, MA F, et al. Neutrophil-to-lymphocyte ratio as a biomarker for predicting the intravenous immunoglobulin-resistant Kawasaki disease[J]. Medicine, 2020, 99(6): e18535. DOI: 10.1097/MD.0000000000018535.
    [14]
    ARORA K, GULERIA S, JINDAL A K, et al. Platelets in Kawasaki disease: Is this only a numbers game or something beyond?[J]. Genes Dis, 2019, 7(1): 62-66.
    [15]
    JIN J, WANG J, LU Y D, et al. Platelet-derived microparticles: A new index of monitoring platelet activation and inflammation in Kawasaki disease[J]. Indian J Pediatr, 2019, 86(3): 250-255. doi: 10.1007/s12098-018-2765-2
    [16]
    HAN S B, LEE S Y. Macrophage activation syndrome in children with Kawasaki disease: Diagnostic and therapeutic approaches[J]. World J Pediatr, 2020, 16(6): 566-574. doi: 10.1007/s12519-020-00360-6
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)  / Tables(5)

    Article Metrics

    Article views (141) PDF downloads(3) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return